Boehringer Ingelheim Animal Health continues support of independent PCV2 research
New large-scale study to investigate effect of tiotropium + olodaterol Respimat® on exacerbations in COPD
For media outside the US, the UK and Canada
OFEV® (nintedanib*) approved in the EU for the treatment of IPF
For media outside UK, US and Canada
Boehringer Ingelheim and Sanofi enter into a strategic contract manufacturing alliance to produce biopharmaceuticals
35 partners from industry and academia to join European research initiative for the prevention of Alzheimer’s dementia
Boehringer Ingelheim and Vanderbilt University join forces to develop new Ras inhibitors for cancer treatment
